Consistently, adoptive transfer of ILC2s expanded in mice treated with IL-33 into mice with DSS-induced colitis, resulting in a significant improvement in the severity of colitis compared to mice without ILC2 transfer (31). This evidence concerns the gene IL33 and colitis.